White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
about
A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injuryPrevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexateDiffusion-weighted MRI in neuro-oncology.Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.GAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networksCognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia.Mathematics intervention for prevention of neurocognitive deficits in childhood leukemiaNeurodevelopmental functioning in very young children undergoing treatment for non-CNS cancersOxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate.Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.Improving the segmentation of therapy-induced leukoencephalopathy in children with acute lymphoblastic leukemia using a priori information and a gradient magnitude threshold.Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia.Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.Brain structure, working memory and response inhibition in childhood leukemia survivors.Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.How PET/MR Can Add Value For Children With Cancer.Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study.Perfusion MRI and SPECT of brain after treatment for childhood acute lymphoblastic leukemia.Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia.MR perfusion, diffusion and BOLD imaging of methotrexate-exposed swine brain.Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes.Assessment of neuropsychological late effects in survivors of childhood leukemia.Intellectual development of childhood ALL patients: a multicenter longitudinal study.
P2860
Q24606514-B9DAA2FE-F47E-4DB6-ACFF-B7E04FD17F86Q28250460-43465C1A-1E3E-413D-BA1A-BF34386A908FQ30838362-02D65F33-3503-4A15-8F02-88CF51CEA877Q33291796-C9883414-1AE5-4D18-BA44-E1E4E9D7318BQ33739935-A8F3E3A6-FD23-4BBC-B51A-B36ECB2EB96AQ34342306-889BC122-711B-4D12-A01B-801B0CE48092Q34630002-4EE9765F-8534-4539-811D-7C1B6CA52AB8Q35635557-2E890A9F-5C52-456E-967A-7F042D1E6B10Q36054142-38AB2105-29CB-4CD7-8BCC-041E23477D85Q36082861-D2B5ABAB-5D5C-4A07-B9D5-3F65CABFE602Q36677457-AFC840D1-771F-40D7-AC2D-D5AF76602B2BQ36677462-D500233F-1DED-42EF-A5F7-BE521320FF57Q36677590-C9077A3F-C227-4B25-8900-620C222A311BQ36677598-39EFC216-4394-46C0-9A77-CB04F5EE7671Q37438016-6618804E-1233-4B81-9FDF-EA6A774BD223Q37627699-90FDFBBF-8469-4999-831E-B31FF599DA9BQ37653619-1E66AA5B-EE5D-4098-B871-7516E2F88749Q37727506-247BD1B6-E28C-4EBF-A612-10B8697EF4CDQ39427334-A4DA3F83-9647-4C3B-90FA-0C8C1323BDB3Q39615014-7BD4096F-2DB7-4C54-B148-1DFBDC831E30Q40135664-DA3D4B8E-02CA-473F-926C-C8D752AE963EQ42528375-A09CC6BC-268F-489C-9F35-152D90ADBBA5Q43247087-9AEAD63E-EBD7-4840-89C0-E64DDCBD8373Q43984753-391293E3-735E-4523-BF80-4498370A99B1Q47561631-0C58145A-2333-4CCE-A124-B879D72552C6Q48960875-32544898-C9BA-4D5B-9F80-932C51576957Q49045380-8FF7B05B-B9C5-4781-8740-33A3B4287198
P2860
White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
White matter changes on MRI du ...... h neuropsychological findings.
@ast
White matter changes on MRI du ...... h neuropsychological findings.
@en
type
label
White matter changes on MRI du ...... h neuropsychological findings.
@ast
White matter changes on MRI du ...... h neuropsychological findings.
@en
prefLabel
White matter changes on MRI du ...... h neuropsychological findings.
@ast
White matter changes on MRI du ...... h neuropsychological findings.
@en
P2093
P2860
P921
P1476
White matter changes on MRI du ...... th neuropsychological findings
@en
P2093
P2860
P304
P356
10.1002/1096-911X(20001101)35:5<456::AID-MPO3>3.0.CO;2-1
P577
2000-11-01T00:00:00Z